J. Carracedo et al., PERTUSSIS-TOXIN-SENSITIVE GTP-BINDING PROTEINS REGULATE ACTIVATION-INDUCED APOPTOTIC CELL-DEATH OF HUMAN NATURAL-KILLER-CELLS, European Journal of Immunology, 25(11), 1995, pp. 3094-3099
Apoptosis of natural killer (NK) cells can be induced by non-specific
physical damage (UV irradiation, heat shock) or by simultaneous ligati
on of the CD16 and the interleukin-2 receptor (IL-2R) molecules, but n
ot with either anti-CD1G or IL-2 alone. Whereas blockade of GTP-bindin
g protein (G protein)-mediated signal transduction using ADP-ribosylat
ing bacterial toxins or the GTPase-resistant GTP analog guanosine 5'-0
-(3-thiotriphosphate (GTP gamma S) does not affect non-specific induct
ion of NK cell apoptosis, such interventions do inhibit induction of a
poptosis by anti-CD16/IL-2. The G proteins involved in the regulation
of activation-induced NK apoptosis are sensitive to pertussis toxin (P
TX) and to the non-specific GTP analog GTP gamma S but not to cholera
toxin, Pseudomonas exotoxin A or diphtheria toxin. A pertussis toxin m
utant that lacks ADP-ribosylating activity, but conserves the membrane
translocating and T cell-mitogenic effects of the native molecule, fa
ils to inhibit NK apoptosis. To exert their apoptosis-inhibitory effec
t, PTX and CTP gamma S must be employed before cells are activated. La
ter addition has no effect, suggesting the implication of G proteins i
n the transmission of apoptosis-inducing signals, but not in the effec
tor stage of apoptosis. Pre-incubation with PTX or GTP gamma S does no
t affect the activation of NK cells by CD16 cross-linking, IL-2 stimul
ation - or both, as assessed by the induction of CD69 expression, prot
ein tyrosine phosphorylation and calcium mobilization. Moreover, neith
er PTX nor GTP gamma S compromise the effector function of NK cells or
the susceptibility of target cells to NK-mediated lysis. These data s
uggest apoptosis as a novel mechanism by which NK responses may be con
trolled in vivo, as well as an experimental and therapeutical strategy
to counteract endogenous down-regulation of NK responses.